Floor Backes

10.0k total citations
179 papers, 3.4k citations indexed

About

Floor Backes is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Floor Backes has authored 179 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Reproductive Medicine, 86 papers in Obstetrics and Gynecology and 62 papers in Oncology. Recurrent topics in Floor Backes's work include Ovarian cancer diagnosis and treatment (84 papers), Endometrial and Cervical Cancer Treatments (84 papers) and Uterine Myomas and Treatments (27 papers). Floor Backes is often cited by papers focused on Ovarian cancer diagnosis and treatment (84 papers), Endometrial and Cervical Cancer Treatments (84 papers) and Uterine Myomas and Treatments (27 papers). Floor Backes collaborates with scholars based in United States, Canada and Spain. Floor Backes's co-authors include David E. Cohn, Ritu Salani, David M. O’Malley, Jeffrey M. Fowler, Larry J. Copeland, Adrian A. Suarez, Paul J. Goodfellow, Robert W. Holloway, Michael Fung Kee Fung and Lynn P. Parker and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Floor Backes

161 papers receiving 3.3k citations

Peers

Countries citing papers authored by Floor Backes

Since Specialization

Citations

This map shows the geographic impact of Floor Backes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Floor Backes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Floor Backes more than expected).

Fields of papers citing papers by Floor Backes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Floor Backes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Floor Backes. The network helps show where Floor Backes may publish in the future.

Co-authorship network of co-authors of Floor Backes

This figure shows the co-authorship network connecting the top 25 collaborators of Floor Backes. A scholar is included among the top collaborators of Floor Backes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Floor Backes. Floor Backes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunotherapy-associated capillary leak syndrome in endometrial cancer: a case report and review of the literature 2025 ·Gynecologic Oncology Reports ·(unknown), (unknown), (unknown), Jason Prosek, Floor Backes	0
2	Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer 2025 ·Future Oncology ·(unknown), (unknown), Jonathan Lim, Jeanne M. Schilder, Jean Hurteau, (unknown), Amanda Golembesky, Floor Backes	0
3	Non-surgical management of recurrent Paget’s disease of the vulva: A case report 2024 ·Gynecologic Oncology Reports ·(unknown), Hannah Kennedy, Floor Backes	0
4	Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial 2024 ·Journal of Clinical Oncology ·Ann H. Klopp, Danielle Enserro, Matthew A. Powell, Marcus E. Randall, Julian C. Schink, Robert S. Mannel, Laura L. Holman, David Bender, (unknown), Floor Backes, Susan Zweizig, Steven Waggoner, Kristin Bradley, (unknown), Parviz Hanjani, Christopher J. Darus, William Small, Higinia R. Cárdenes, Jonathan Feddock, David S. Miller	10
5	Associations between race and ethnicity and treatment setting among gynecologic cancer patients 2024 ·Gynecologic Oncology ·(unknown), (unknown), Floor Backes, Casey Cosgrove, Allison Quick, Britton Trabert, (unknown), Ashley S. Felix	0
6	Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer 2023 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Floor Backes, David E. Cohn, Paul J. Goodfellow, Casey Cosgrove	10
7	NRG‐GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer 2023 ·Cancer ·B.J. Rimel, Danielle Enserro, David Bender, (unknown), Annie Tan, (unknown), Mark E. Borowsky, John W. Moroney, Andrea Wahner Hendrickson, Floor Backes, Elizabeth M. Swisher, Matthew A. Powell, Helen Mackay	6
8	Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer 2023 ·JAMA Network Open ·(unknown), (unknown), Floor Backes, Ashley S. Felix	18
9	PO005LBA/#1579 A randomized, phase II/III study of pegylated-liposomal-doxorubicin and atezolizumab (IND #134427) versus pegylated-liposomal-doxorubicin, bevacizumab and atezolizumab versus pegylated-liposomal-doxorubicin and bevacizumab in platinum-resistant ovarian cancer (NRG-GY009) 2023 ·Roisin E. O’Cearbhaill, Michael W. Sill, (unknown), Steven Waggoner, Rachel N. Grisham, Floor Backes, Robert S. Mannel, János L. Tanyi, Matthew A. Powell, Cara Mathews, Sharad Ghamande, Leah McNally, Alexander Olawaiye, David Bender, Linda Duska, Heather A. Lankes, Dmitriy Zamarin, Russell J. Schilder, Michael A. Bookman, Carol Aghajanian	0
10	Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma 2023 ·Gynecologic Oncology ·Joyce N. Barlin, (unknown), Ashar Ata, Béatrice Cormier, (unknown), Ritu Salani, Floor Backes, Kimberly Levinson, Leigh A. Cantrell, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Patrick Timmins	3
11	Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer 2023 ·Gynecologic Oncology ·(unknown), Jenna M. Patterson, (unknown), (unknown), (unknown), Floor Backes, (unknown), (unknown), David M. O’Malley, (unknown), (unknown)	17
12	2022-RA-324-ESGO Phase 2 results from the LIO-1 STUDY (NCT04042116; ENGOT-GYN3/AGO/LIO): efficacy and safety of lucitanib + nivolumab in patients with advanced gynaecological malignancies 2022 ·International Journal of Gynecological Cancer ·Nicole Concin, Manish R. Patel, Vicky Makker, Ana Oaknin, Sandro Pignata, Floor Backes, Antonio González-Martı́n, Ramez N. Eskander, Bhavana Pothuri, Debra L. Richardson, Angeles Alvarez Secord, Els Van Nieuwenhuysen, Joyce F. Liu, Fernanda Musa, Richard T. Penson, Kenton Wride, Rachel L. Dusek, T. Cameron, Erika Hamilton	0
13	530P PRIMA/ENGOT-OV26/GOG-3012 study: Updated long-term PFS and safety 2022 ·Annals of Oncology ·Andrew Martin, Bhavana Pothuri, I. Vergote, (unknown), Mansoor R. Mirza, (unknown), (unknown), Gilles Freyer, Floor Backes, Klaus Baumann, Andrés Redondo, R. G. Moore, Christof Vulsteke, (unknown), (unknown), (unknown), Natalie Compton, B.J. Monk	16
14	ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2−/− Ovarian Cancer Cells 2019 ·Molecular Cancer Therapeutics ·Lu Liu, Shurui Cai, Chunhua Han, Ananya Banerjee, Dayong Wu, (unknown), (unknown), Junran Zhang, Xiaoli Zhang, Eric McLaughlin, Ming Yin, Floor Backes, Arnab Chakravarti, Yanfang Zheng, Qi‐En Wang	51
15	Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center 2018 ·Gynecologic Oncology ·Adam C. ElNaggar, Erinn M. Hade, David M. O’Malley, Margaret Liang, Larry J. Copeland, Jeffrey M. Fowler, Ritu Salani, Floor Backes, David E. Cohn	12
16	Sparse feature selection for classification and prediction of metastasis in endometrial cancer 2017 ·BMC Genomics ·Mehmet Eren Ahsen, Todd Boren, Nitin K. Singh, Burook Misganaw, David G. Mutch, Kathleen N. Moore, Floor Backes, Carolyn K. McCourt, Jayanthi Lea, David S. Miller, Michael A. White, M. Vidyasagar	19
17	A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer 2016 ·Journal of Minimally Invasive Gynecology ·David E. Cohn, (unknown), Laura Huffman, Ritu Salani, Jeffrey M. Fowler, Larry J. Copeland, David M. O’Malley, Floor Backes, Eric Eisenhauer, Mahmoud Abdel‐Rasoul, Erika Puente-Poushnejad, Sergio D. Bergese	18
18	Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer 2016 ·Gynecologic Oncology ·Floor Backes, Christopher J. Walker, Paul J. Goodfellow, Erinn M. Hade, Garima Agarwal, David G. Mutch, David E. Cohn, Adrian A. Suarez	71
19	Predicting Inpatient Stay Lasting 2 Midnights or Longer After Robotic Surgery for Endometrial Cancer 2015 ·Journal of Minimally Invasive Gynecology ·Margaret Liang, (unknown), Kellie S. Rath, Erinn M. Hade, Aine Clements, Floor Backes, Eric Eisenhauer, Ritu Salani, David M. O’Malley, Jeffrey M. Fowler, David E. Cohn	7
20	Are prediction models for Lynch syndrome valid for probands with endometrial cancer? 2009 ·Familial Cancer ·Floor Backes, Heather Hampel, (unknown), Luis Vaccarello, George Lewandowski, Jeffrey A. Bell, Gary C. Reid, Larry J. Copeland, Jeffrey M. Fowler, David E. Cohn	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact